MedPath

Characterization of Methylation Patterns in Lung Cancer

Completed
Conditions
Lung Cancer
Registration Number
NCT02373917
Lead Sponsor
Nucleix Ltd.
Brief Summary

In this study the investigators will collect Blood,sputum and saliva samples for Characterization of Methylation Patterns in lung Cancer.

Detailed Description

Lots of information about the relationship between changes in methylation patterns and various diseases are accumulated in recent years. Characterization of methylation changes that occur in cancer may contribute to the development of methods for early detection of cancer by detecting cancer cells in liquids. Early detection of such changes and their correlation examining different cancers may lead to a diagnostic tool for the early detection of cancers and improve the treatment of these patients. Detection by molecular analysis can be a sensitive method and non-invasive early diagnosis of the disease In this study the investigators will collect Blood,sputum and saliva samples for Characterization of Methylation Patterns in lung Cancer.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
683
Inclusion Criteria
  • Patients with suspected lung tumor
Read More
Exclusion Criteria
  • Patients who have active disease other than lung cancer during the sample collecting
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Characterization of Methylation Patterns in lung Cancertwo years

Collecting and analyzing samples

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sha'are Tzedaek Medical Center

🇮🇱

Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath